It’s been a couple of months since pharma’s annual JP Morgan Chase Healthcare Conference, where the mood around pharma M&A this year was optimistic, albeit with a few caveats.
When US President Joe Biden talks about his Cancer Moonshot, he's not literally talking about the moon - he's referencing the legendary innovation push that got Americans to the moon in 196
At Reuters Pharma USA in March, ZS Associates' Maria Whitman sat down with pharmaphorum to discuss why it's time to reinvent pharma's marketing strategy
The biopharma industry has lost another leading figure with the passing of Andy Zoltners, co-founder of ZS Associates, on the 40th anniversary of the company.
Modern medicine moves ever more to precision, personalised medicine, and precision dosing is critical in a world that recognises biological individuality – especially when it comes to paedi
